サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1424998

膵臓がん治療・診断市場：治療タイプ別、診断別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測

Pancreatic Cancer Therapeutics & Diagnostics Market, By Treatment Type, Diagnostic, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 290 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
膵臓がん治療・診断市場：治療タイプ別、診断別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2024年02月07日
発行: AnalystView Market Insights
ページ情報: 英文 290 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

膵臓がん治療・診断市場規模は2022年に24億7,060万米ドルとなり、2023年から2030年にかけてCAGR 5.5%で拡大する見込みです。

膵臓がん治療・診断市場-市場力学

膵臓がんの罹患率の上昇、分子生物学、薬剤開発、診断技術の進歩が市場需要を促進すると予測される

市場成長の原動力は、膵臓がんの罹患率の上昇、分子生物学、薬剤開発、診断技術の進歩などの要因です。研究開発イニシアチブの増加、有利な償還シナリオ、革新的製品の導入により、市場は大きく拡大する態勢にあります。特筆すべきは、2019年1月、Van Andel Research Instituteの科学者らが、既存の検査と組み合わせることで、膵臓がんのほぼ70％を5％未満の偽陽性率で検出できる新規血液検査（CA19-9検査）を発表したことです。さらに、Myriad Genetics Inc.は2021年1月、膵がんスクリーニングに使用されるBRACAnalysis Diagnostic Systemが日本の厚生労働省から保険償還を受けると発表しました。2020年10月、Oncolytics Biotech Inc.は、転移性膵がんに対するペラレオレップとアテゾリズマブの有効性を評価する第1/2相試験のためのロシュおよびAIOとの提携を発表しました。こうした新興国市場の開拓は、予測期間を通じて市場の成長に好影響を与えると予想されます。

膵臓がん治療・診断市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界の膵臓がん治療薬・診断薬市場は予測期間（2023-2030年）に約5.5%のCAGRで毎年成長すると予測されています。

がん治療薬・診断薬市場は、膵臓がんの罹患率の上昇、分子生物学、医薬品開発、診断技術の進歩により、著しい速度で成長すると予測される

エンドユーザー別では、病院が2022年に最大の市場シェアを示すと予測されます。

治療法別では、化学療法が2022年の主要タイプでした。

地域別では、北米が2022年に主要な収益源となります。

膵臓がん治療・診断市場-セグメンテーション分析：

世界の膵臓がん治療・診断市場は、治療タイプ、診断、エンドユーザー別、地域別に区分されます。

市場は治療に基づいて3つのカテゴリーに分けられる：化学療法、手術、その他の治療予測期間中、化学療法分野は調査市場において重要な役割を果たすと予測されます。化学療法は膵臓がんを治療する主要な方法であり、膵臓がん細胞の増殖と分裂を阻害し、効果的に死滅させることで機能します。これらの化学療法薬は全身的に作用し、血流にのって全身のがん細胞を標的にしてダメージを与えます。

市場はエンドユーザー別に4つのカテゴリーに分類される：病院、診療所、研究所、その他。2022年、膵臓がん診断薬市場は、売上高シェアで病院分野が大きくリードしています。この優位性は、個別化医療に対する意識の高まり、利用しやすいヘルスケアサービスの強化、病院を訪れる患者の増加、戦略的イニシアチブの重視の高まりなど、いくつかの要因によるもので、これらすべてが病院セグメントの成長を後押ししています。

膵臓がん治療・診断市場-地理的洞察

地理的には、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。予測期間中、北米が市場を独占すると予想されます。対象疾患の罹患率の上昇と、疾患の早期発見を支援する営利・非営利団体の試みの増加が、北米地域の拡大を後押ししています。調査活動を支援し、この病気に対する認識を高める有名な団体にPancreatic Cancer Action Networkがあります。

膵臓がん治療・診断市場-競合情勢：

膵臓がん治療・診断市場では、各社が膵臓がん治療・診断の需要増に対応するための戦略を積極的に推進しています。膵がん治療薬の分野では、製薬企業やバイオテクノロジー企業が新製品の発売、提携、共同研究、研究イニシアティブなど、さまざまな活動に取り組んでいます。

目次

第1章 膵臓がん治療・診断市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 膵臓がん治療・診断の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 膵臓がん治療・診断業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 膵臓がん治療・診断市場：COVID-19の影響分析

  • プレ新型コロナウイルス感染症の影響分析
  • ポスト新型コロナウイルス感染症の影響分析

第6章 膵臓がん治療・診断市場情勢

  • 膵臓がん治療・診断市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 膵臓がん治療・診断市場- 治療タイプ別

  • 概要
    • 治療タイプ別のセグメントシェア分析
    • 標的療法
    • 化学療法
    • 手術
    • その他の治療

第8章 膵臓がん治療・診断市場- 診断別

  • 概要
    • 診断別のセグメントシェア分析
    • イメージング
    • 生検
    • 超音波内視鏡検査
    • その他の診断

第9章 膵臓がん治療・診断市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院
    • クリニック
    • 研究室
    • その他

第10章 膵臓がん治療・診断市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 膵臓がん治療・診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Myriad Genetics Inc.
    • Pfizer Inc.
    • Novartis AG
    • Bristol-Myers Squibb Company
    • AstraZeneca PLC
    • Amgen Inc.
    • Viatris Inc.
    • Boston Scientific Corporation
    • FUJIFILM Holdings Corporation
    • Canon Inc.（canon Medical Systems Corporation）

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Treatment Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type 2018-2030 (USD Million)
  • TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Diagnostics Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Diagnostics
  • TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics 2018-2030 (USD Million)
  • TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: End Users Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End Users
  • TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users 2018-2030 (USD Million)
  • TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
  • TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
  • TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)

List of Figures

  • FIGURE Pancreatic Cancer Therapeutics & Diagnostics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Treatment Type segment market share analysis, 2022 & 2030
  • FIGURE Treatment Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Diagnostics segment market share analysis, 2022 & 2030
  • FIGURE Diagnostics segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End Users segment market share analysis, 2022 & 2030
  • FIGURE End Users segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Pancreatic Cancer Therapeutics & Diagnostics Market share and leading players, 2022
  • FIGURE Europe Pancreatic Cancer Therapeutics & Diagnostics Market share and leading players, 2022
  • FIGURE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market share and leading players, 2022
  • FIGURE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market share and leading players, 2022
  • FIGURE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Pancreatic Cancer Therapeutics & Diagnostics Market share analysis by country, 2022
  • FIGURE Germany Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market share analysis by country, 2022
  • FIGURE India Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market share analysis by country, 2022
  • FIGURE Brazil Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Pancreatic Cancer Therapeutics & Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2198

REPORT HIGHLIGHT

Pancreatic Cancer Therapeutics & Diagnostics Market size was valued at USD 2,470.6 Million in 2022, expanding at a CAGR of 5.5% from 2023 to 2030.

Pancreatic cancer therapeutics and diagnostics encompass medical procedures for both the diagnosis and subsequent treatment of pancreatic cancer. Globally, pancreatic cancer stands as a significant contributor to cancer-related fatalities, with the disease burden escalating rapidly. According to the American Cancer Society, the 5-year relative survival rates are approximately 44% for localized cases, 15% for regional cases, and 3% for distant cases. In response, healthcare professionals and authorities are underscoring the need to develop and commercialize precise screening methods to monitor prevalence levels.

Pancreatic Cancer Therapeutics & Diagnostics Market- Market Dynamics

Rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology is expected to propel the market demand

The market growth is driven by factors such as the rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology. The market is poised for significant expansion due to increased research and development initiatives, favorable reimbursement scenarios, and the introduction of innovative products. Notably, in January 2019, scientists at the Van Andel Research Institute introduced a novel blood test (CA19-9 test) that, when combined with an existing test, can detect nearly 70% of pancreatic cancers with a false-positive rate of less than 5%. Additionally, Myriad Genetics Inc. announced in January 2021 that its BRACAnalysis Diagnostic System, used for pancreatic cancer screening, would receive reimbursement from Japan's Ministry of Health, Labour, and Welfare, potentially expanding the patient pool for genetic testing in Japan.Collaborations are also shaping the market positively. In October 2020, Oncolytics Biotech Inc. disclosed a collaboration with Roche and AIO for a phase 1/2 trial evaluating the efficacy of pelareorep and atezolizumab in treating metastatic pancreatic cancer. These developments are anticipated to have a favorable impact on market growth throughout the forecast period.

Pancreatic Cancer Therapeutics & Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global Pancreatic Cancer Therapeutics & Diagnostics Market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2023-2030)

The Cancer Therapeutics & Diagnostics Market is projected to grow at a significant rate due to rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology

Based on end user, hospital was predicted to show maximum market share in the year 2022

Based on Treatment, chemotherapy segment was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Pancreatic Cancer Therapeutics & Diagnostics Market- Segmentation Analysis:

The Global Pancreatic Cancer Therapeutics & Diagnostics Market is segmented on the basis of Treatment Type, Diagnostic, By End User, and Region.

The market is divided into three categories based on Treatment: Chemotherapy. Surgery, Other Treatments. Over the forecast period, it is anticipated that the chemotherapy segment will play a significant role in the studied market. Chemotherapy stands as a primary method of treating pancreatic cancer, functioning by impeding the growth and division of pancreatic cancer cells, effectively killing them. These chemotherapy drugs operate systemically, traveling through the bloodstream to target and damage cancer cells throughout the entire body.

The market is divided into four categories based on End User: Hospitals, Clinics, Laboratories, Others. In 2022, the pancreatic cancer diagnostics market was predominantly led by the hospitals segment in terms of revenue share. This prominence can be attributed to several factors, including heightened awareness of personalized medicines, enhancements in accessible healthcare services, an uptick in patient visits to hospitals, and an increasing emphasis on strategic initiatives, all of which are bolstering the growth of the hospital segment.

Pancreatic Cancer Therapeutics & Diagnostics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The target illness's rising incidence and the rise in for-profit and nonprofit organizations' attempts to support early disease identification are driving the expansion of the North American area. One well-known group that supports research efforts and raises awareness of the disease is the Pancreatic Cancer Action Network.

Pancreatic Cancer Therapeutics & Diagnostics Market- Competitive Landscape:

In the pancreatic cancer therapeutic & diagnostic market, companies are actively pursuing strategies to capitalize on the increasing demand for Pancreatic Cancer Therapeutics & Diagnostics. In the field of pancreatic cancer therapeutics, pharmaceutical and biotechnology companies are involved in various activities, including new product launches, partnerships, collaborations, and research initiatives.

Recent Developments:

In January 2023, the evaluation of the radiotracer, 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46, in pancreatic cancer imaging through a clinical study was released by Mayo Clinic.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET KEY PLAYERS

  • Myriad Genetics Inc.
  • Pfizer Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • AstraZeneca PLC
  • Amgen Inc.
  • Viatris Inc.
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Canon Inc. (canon Medical Systems Corporation)

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY TREATMENT TYPE

  • Targeted Therapies
  • Chemotherapy
  • Surgery
  • Other Treatments

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTIC

  • Imaging
  • Biopsy
  • Endoscopic Ultrasound
  • Other Diagnostics

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY END USER

  • Hospitals
  • Clinics
  • Laboratories
  • Others

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pancreatic Cancer Therapeutics & Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Treatment Type
    • 2.1.2. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Diagnostics
    • 2.1.3. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by End Users
    • 2.1.4. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Country
    • 2.1.5. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Pancreatic Cancer Therapeutics & Diagnostics Key Market Trends

  • 3.1. Pancreatic Cancer Therapeutics & Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pancreatic Cancer Therapeutics & Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pancreatic Cancer Therapeutics & Diagnostics Market Opportunities
  • 3.4. Pancreatic Cancer Therapeutics & Diagnostics Market Future Trends

4. Pancreatic Cancer Therapeutics & Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pancreatic Cancer Therapeutics & Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pancreatic Cancer Therapeutics & Diagnostics Market Landscape

  • 6.1. Pancreatic Cancer Therapeutics & Diagnostics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pancreatic Cancer Therapeutics & Diagnostics Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
    • 7.1.2. Targeted Therapies
    • 7.1.3. Chemotherapy
    • 7.1.4. Surgery
    • 7.1.5. Other Treatments

8. Pancreatic Cancer Therapeutics & Diagnostics Market - By Diagnostics

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnostics, 2022 & 2030 (%)
    • 8.1.2. Imaging
    • 8.1.3. Biopsy
    • 8.1.4. Endoscopic Ultrasound
    • 8.1.5. Other Diagnostics

9. Pancreatic Cancer Therapeutics & Diagnostics Market - By End Users

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Users, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Laboratories
    • 9.1.5. Others

10. Pancreatic Cancer Therapeutics & Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Pancreatic Cancer Therapeutics & Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Myriad Genetics Inc.
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Novartis AG
    • 11.2.4. Bristol-Myers Squibb Company
    • 11.2.5. AstraZeneca PLC
    • 11.2.6. Amgen Inc.
    • 11.2.7. Viatris Inc.
    • 11.2.8. Boston Scientific Corporation
    • 11.2.9. FUJIFILM Holdings Corporation
    • 11.2.10. Canon Inc. (canon Medical Systems Corporation)

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us